This Viewpoint reviews systems in place to monitor postlicensure vaccine safety, and recommends harmonizing end points and protocols across vaccine trials and surveillance systems to enable timely identification and reliable evaluation of potential...
Quick answer — it’s complicated. Let’s start with a clinical anecdote — rightfully considered the weakest form of evidence, yet paradoxically holding great power over us because we’re imperfect humans. It’s the way we’re wired. In April, a patient...
This cross-sectional study assesses drug coverage, formulary restrictions, median retail prices, and annual out-of-pocket costs associated with commonly used insulin products across Medicare Part D plans.
How the world’s greatest public health organization was brought to its knees by a virus, the president and the capitulation of its own leaders, causing damage that could last much longer than the coronavirus.
This Viewpoint considers how COVID-19 vaccines can be distributed strategically, ethically, and legally given conflicts between consensus public health recommendations to prioritize allocation to disadvantaged racial and ethnic minorities and laws...
Walid Gellad, MD MPHViewpoint in @JAMA_current discussing legal issues with prioritizing Covid vaccine based on race, versus measures like "Area Deprivation Index."
Let's hope Covid vaccine distribution is not an issue that goes to the Courts.
France imposed a curfew on Paris and other major cities, and other countries are taking similar steps as record caseloads fill hospitals and governments try to respond without lockdowns.
Walid Gellad, MD MPHA NYT article is out this afternoon that calmly summarizes what I tweet yelled at everyone earlier.
Europe sees resurgence of Covid, new social restrictions, and pressure on hospitals. The US has advance warning.